» Articles » PMID: 19480971

Radiation Response in Two HPV-infected Head-and-neck Cancer Cell Lines in Comparison to a Non-HPV-infected Cell Line and Relationship to Signaling Through AKT

Overview
Specialties Oncology
Radiology
Date 2009 Jun 2
PMID 19480971
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Human papilloma virus (HPV)-associated cancers of the head and neck (H&N) are increasing in frequency and are often treated with radiation. There are conflicting data in the literature regarding the radiation response in the presence of HPV infection, with some data suggesting they may be more sensitive to radiation. There are few studies looking at in vitro effects of HPV and further sensitization by inhibitors of specific signaling pathways. We are in the process of starting a clinical trial in H&N cancer patients using nelfinavir (NFV) (which inhibits Akt) and it would be important to know the effect of HPV on radiation response +/- NFV.

Methods And Materials: Two naturally infected HPV-16 cell lines (UPCI-SCC90 and UMSCC47) and the HPV-negative SQ20B H&N squamous carcinoma cells were used. Western blots with or without 10 uM NFV were done to evaluate signaling from the PI3K-Akt pathway. Clonogenic assays were done in the three cell lines with or without NFV.

Results: Both UPCI-SCC90 and UMSCC47 cells were sensitive to radiation as compared with SQ20B and the degree corresponded to Akt activation. The SQ20B cell line has an activating mutation in EGFR resulting in phosphorylation (P) of Akt; UMSCC47 has decreased P-phosphatase and TENsin (PTEN), resulting in increased P-Akt; UPCI-SCC90 had overexpression of P-PTEN and decreased P-Akt. NFV resulted in downregulation of Akt in all three cell lines, resulting in sensitization to radiation.

Conclusions: HPV-infected H&N cancers are sensitive to radiation. The degree of sensitivity correlates to Akt activation and they can be further sensitized by NFV.

Citing Articles

De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: evolving paradigms and future strategies.

Chen A Front Oncol. 2023; 13:1175578.

PMID: 37576899 PMC: 10413127. DOI: 10.3389/fonc.2023.1175578.


Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair.

Bruyere D, Roncarati P, Lebeau A, Lerho T, Poulain F, Hendrick E Theranostics. 2023; 13(3):1130-1149.

PMID: 36793865 PMC: 9925306. DOI: 10.7150/thno.78091.


Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.

Kim S, Woo S, Noh J, Lee M, Lee Y, Lee J BMC Cancer. 2022; 22(1):1077.

PMID: 36261806 PMC: 9583594. DOI: 10.1186/s12885-022-10184-4.


Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma.

Karukonda P, Odhiambo D, Mowery Y Mol Carcinog. 2021; 61(2):225-238.

PMID: 34964992 PMC: 8799519. DOI: 10.1002/mc.23384.


7-Epitaxol Induces Apoptosis and Autophagy in Head and Neck Squamous Cell Carcinoma through Inhibition of the ERK Pathway.

Kumar V, Hsieh M, Mahalakshmi B, Chuang Y, Lin C, Lo Y Cells. 2021; 10(10).

PMID: 34685613 PMC: 8534141. DOI: 10.3390/cells10102633.


References
1.
Reimers N, Kasper H, Weissenborn S, Stutzer H, Preuss S, Hoffmann T . Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007; 120(8):1731-8. DOI: 10.1002/ijc.22355. View

2.
Atula S, Grenman R, Kujari H, Syrjanen S . Detection of human papillomavirus (HPV) in laryngeal carcinoma cell lines provides evidence for a heterogeneic cell population. Eur J Cancer. 1999; 35(5):825-32. DOI: 10.1016/s0959-8049(98)00424-9. View

3.
Komarova E, Kondratov R, Wang K, Christov K, Golovkina T, Goldblum J . Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene. 2004; 23(19):3265-71. DOI: 10.1038/sj.onc.1207494. View

4.
Saxena A, Yashar C, Taylor D, Gercel-Taylor C . Cellular response to chemotherapy and radiation in cervical cancer. Am J Obstet Gynecol. 2005; 192(5):1399-403. DOI: 10.1016/j.ajog.2004.12.045. View

5.
Ferris R, Martinez I, Sirianni N, Wang J, Lopez-Albaitero A, Gollin S . Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer. 2005; 41(5):807-15. DOI: 10.1016/j.ejca.2004.11.023. View